The Diskus™: A review of its position among dry powder inhaler devices

International Journal of Clinical Practice

Volumn 61, Issue 6, 2007, Pages 1022-1036

  Chrystyn, H ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETASONE DIPROPIONATE PLUS SALBUTAMOL; BUDESONIDE; CROMOGLYCATE DISODIUM; FENOTEROL; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; IPRATROPIUM BROMIDE; MOMETASONE FUROATE; SALBUTAMOL; SALMETEROL; TERBUTALINE; TIOTROPIUM BROMIDE; ANTIASTHMATIC AGENT;

AGING; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; HEALTH CARE COST; HUMAN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PEDIATRICS; POWDER INHALER; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; EQUIPMENT DESIGN; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; STANDARD;

ADMINISTRATION, INHALATION; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION;

EID: 34248348182     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01382.x     Document Type: Review

References (100)

1. Freedman T. Medihaler therapy for bronchial asthma: a new type of aerosol therapy. Postgrad Med J 1956 20 : 667 73.
2. Brompton Hospital/MRC Collaborative trial. Double-blind trial comparing two dosage schedules of beclomethasone dipropionate aerosol in the treatment of chronic bronchial asthma. Lancet 1974 2 : 303 7.
3. Boyd G. The continued need for MDIs. J Aerosol Med 1995 8 (Suppl. 1 S9 12.
4. Ross DL, Gabrio BJ. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system. J Aerosol Med 1999 12 : 151 60.
5. Bell JH, Hartley PS, Cox JSG. Dry powder aerosols 1: a new powder inhalation device. J Pharm Sci 1971 10 : 1559 64.
6. Amirav I, Goren A, Pawlowski NA. What do paediatricians know about the correct use of inhalers and spacer devices? J Allergy Clin Immunol 1994 94 : 669 75.
7. Cochrane GM, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000 117 : 542 50.
8. Noakes TJ. CFCs, their replacements and the ozone layer. J Aerosol Med 1995 8 (Suppl. 1 S3 7.
9. Hetzel M, Clark T. Comparison of salbutamol Rotahaler with conventional pressurized aerosol. Clin Allergy 1977 7 : 563 8.
10. Edmunds AT, McKenzie S, Tooley M, Godfrey S. A clinical comparison of beclomethasone dipropionate delivered by pressurized aerosol and as a powder from a Rotahaler. Arch Dis Child 1979 54 : 233 5.
11. Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 1980 20 : 237 66.
12. Taylor A, Gustafsson P. Do all dry powder inhalers show the same pharmaceutical performance? Int J Clin Pract 2005 59 (Suppl. 149 7 12.
13. Brocklebank D, Wright J, Cates C, on behalf of The National Health Technology Assessment Inhaler Review Group. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering corticosteroids in asthma. BMJ 2001 323 : 1 7.
14. Ram FSF, Wright J, Brocklebank D, White JES, on behalf of The National Health Technology Assessment Inhaler Review Group. Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering β2-agonists bronchodilators in asthma. BMJ 2001 323 : 1 7.
15. Chrystyn H. Do patients show the same level of adherence with all dry powder inhalers? Int J Clin Pract 2005 59 : 19 25.
16. Hallworth GW. An improved design of powder inhaler. Br J Clin Pharmacol 1977 4 : 689 90.
17. Chodosh S, Flanders JS, Kesten S, Serby CW, Hochrainer D, Witek TJ. Effective delivery of particles with the Handihaler® dry powder inhalation system over a range of chronic obstructive pulmonary disease severity. J Aerosol Med 2001 14 : 309 15.
18. Dahl R, Backer V, Ollgard B et al. Assessment of patient performance of the Handihaler® compared with the metered dose inhaler four weeks after instruction. Respir Med 2003 97 : 1126 33.
19. Tarsin W, Al-Showair RAM, Corrado OJ, Pearson SB, Chrystyn H. Peak inhalation rates (PIFRs) of COPD patients when using a metered dose inhaler (MDI) and recently introduced dry powder inhalers (DPI). Thorax 2003 58 (Suppl. 111 ii73.
20. Al-Fadhl SA, Assi KH, Clark BJ, Chrystyn H. Tiotropium dose emission is influenced by the inhalation flow and the recommended two inhalations for each dose. Eur Respir J 2005 26 (Suppl. 49 125s 6.
21. Moore AC, Stone S. Meeting the needs of patients with COPD: patients' preference for the Diskus compared with the Handihaler. Int J Clin Pract 2004 58 : 444 50.
22. Franks M, Briggs P. Use of a cognitive ergonomics approach to compare usability of a mutidose dry powder inhaler and capsule dry powder inhaler: an open-label, randomized, controlled study. Clin Ther 2004 26 : 1791 9.
23. Wetterlin K. Turbuhaler: a new powder inhaler for administration of drugs to the airways. Pharm Res 1988 5 : 506 8.
24. Vidgren M, Silvasti M, Vidgren P, Sormunen H, Laurikainen K, Korhonen P. Easyhaler multiple dose powder inhaler - practical and effective alternative to the pressurized MDI. Aerosol Sci Technol 1995 22 : 335 45.
25. Warren S, Taylor G. Effect of inhalation flow profiles on the deposition of radiolabelled BDP from a novel dry powder inhaler (DPI. Clickhaler), a conventional metered dose inhaler (MDI), and MDI plus spacer. In : Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery VI. Buffalo Grove, IL : Interpharm Press, 1998 : 453 5.
26. Yang TT, Fan BJ, Kenyon D. Evaluation of the new mometasone furoate dry powder inhaler agglomerate formulation and deagglomeration during inhalation. Chest 2000 118 : 98S.
27. Berner B, Fyrnys B, de Boer A, Gottenhauer W, Wolf-Heuss E. Asta Medica multidose dry powder inhaler. In : Dalby RN, Byron PR, Farr SJ, eds. Respiratory Drug Delivery VI. Buffalo Grove, IL : Interpharm Press, 1998 : 475 7.
28. Sumby BS, Crucher KM, Smith IJ et al. Dose reliability of the Serevent Diskhaler system. Pharm Tech Int 1993 5 (June) : 20 7.
29. European Pharmacopeia. Preparations for Inhalation. European Pharmacopeia Supplement, 2001 2.9.18.
30. FDA US. Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products, Chemistry, Manufacturing and Controls Documentation. US Dept of Health and Human Sciences, FDA Center for Drug Evaluation and Research (CDER), 1998; Rockville, US.
31. Brain JD, Blanchard JD. Mechanisms of particle deposition and clearance. In : Moren F, Dolovich MB, Newhouse MT, Newman SP, eds. Aerosols in Medicine: Principles, Diagnosis and Therapy. Amsterdam : Elsevier, 1993 : 351 74.
32. Hill LS, Slater AL. A comparison of the performance of two modern multidose dry powder asthma inhalers. Respir Med 1998 92 : 105 10.
33. de Boer AH, Gjaltema D, Hagedoorn P. Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers. Part 2: Effect of peak flow rate (PIFR) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers. Int J Pharm 1996 138 : 45 56.
34. Tarsin W, Assi KH, Chrystyn H. In vitro and inter-inhaler flow rate-dependent dosage emission from a combination of budesonide and formoterol in a dry powder inhaler. J Aerosol Med 2004 17 : 25 32.
35. Palander A, Mattila T, Karka M, Muttonen E. In vitro comparison of three salbutamol-containing multidose dry powder inhalers. Clin Drug Invest 2000 20 : 25 33.
36. Fuller R. The DiskusTM: a new multi-dose powder device - efficacy and comparison with TurbuhalerTM. J Aerosol Med 1995 8 (Suppl. 2 S11 7.
37. Brindley A, Sumby BS, Smith IJ, Prime DA, Haywood PA, Grant AC. Design, manufacture and dose consistency of the Serevent Diskus inhaler. Pharm Technol Eur Biopharm 1995 7 : 14 22.
38. Prime D, Slater AL, Haywood PA, Smith IJ. Assessing dose delivery from the Flixotide Diskus inhaler - a multi-dose powder inhaler. Pharm Tech Eur 1996 8 : 23 36.
39. Ashurst IC, Prime D Haywood PA. Development of a dry powder inhaler device containing a combination of salmeterol and fluticasone propionate. Eur Respir J 1998 12 (Suppl. 28 93s.
40. Prime D, Parkes PA, Petchey L, Slater AL, Woodhouse RN. Evaluation of the pharmaceutical performance of two dry powder inhalers: a comparison of Diskus and Turbuhaler inhalers. Am J Respir Crit Care Med 1996 153 : A62.
41. Malton A, Sumby BS, Smith IJ. A comparison of in vitro drug delivery from two multidose powder inhalation devices. Eur J Clin Res 1995 7 : 177 93.
42. Martonen TB, Katz I, Fults K, Hickey AJ. Use of analytically defined estimates of aerosol respirable fraction to predict lung deposition patterns. Pharm Res 1992 9 : 1634 9.
43. Newman SP. How well do in vitro particle size measurements predict drug delivery in vivo? J Aerosol Med 1998 11 (Suppl. 1 S97 104.
44. Steckel H, Müller BW. In vitro evaluation of dry powder inhalers 1: drug deposition of commonly used devices. Int J Pharm 1997 154 : 19 29.
45. Bisgaard H, Klug B, Sumby BS, Burnell PKP. Fine particle mass from the Diskus inhaler and Turbuhaler in children with asthma. Eur Respir J 1998 11 : 1111 5.
46. Tarsin WY, Pearson SB, Assi KH, Chrystyn H. Emitted dose estimates from Seretide Diskus and Symbicort Turbuhaler following inhalation by severe asthmatics. Int J Pharm 2006 316 : 131 7
47. Bracamonte T, Schauer U, Emeryk A, Godwood A, Balsara S. Efficacy and safety of salmeterol/fluticasone propionate combination delivered by the DiskusTM or pressurised metered dose inhaler in children with asthma. Clin Drug Invest 2005 25 : 1 11.
48. Hindle M, Byron PR. Dose emissions from marketed dry powder inhalers. Int J Pharm 1995 116 : 169 77.
49. Gustaffson P, Andersson H, Glad M. Comparison of total and fine drug particle mass generated from two dry powder inhalers (DPIs) by 4 year old children with asthma. Eur Respir J 2002 20 (Suppl. 38 429s.
50. Kokot M. Selection of a personal dry powder inhaler based on peak inspiratory flow measurements in selected groups of patients with bronchial obstruction. Pol Merkur Lekarski 2000 9 : 672 6.
51. Pederson S, Hansen OR, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child 1990 65 : 308 10.
52. Melchor R, Biddiscome MF, Mak VHF, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction. Thorax 1993 48 : 506 11.
53. Borgström L, Bondesson E, Moren F, Trofast E, Newman SP. Lung deposition of budesonide inhaled via Turbohaler: a comparison with terbutaline sulphate in normal subjects. Eur Respir J 1994 7 : 69 73.
54. Lindsay DA, Russell NL, Thompson JE et al. A multicentre comparison of the efficacy of terbutaline turbuhaler and salbutamol pressurized metered dose inhaler in hot, humid regions. Eur Respir J 1994 7 : 342 5.
55. Meakin BJ, Cainey JM, Woodcock PM. Simulated 'in-use' and 'mis-use' aspects of the delivery of terbutaline sulphate from Bricanyl TurbohalerTM dry powder inhalers. Int J Pharm 1995 119 : 103 8.
56. Borgström L, Asking L, Lipniunas P. An in vivo and in vitro comparison of two powder inhalers following storage at hot/humid conditions. J Aerosol Med 2005 18 : 304 10.
57. Serra-Batlles J, Plaza V, Badiola C, Morejon E. Patient perception and acceptability of multidose dry powder inhalers: A randomized crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002 15 : 59 64.
58. Van Beerendonk I, Mesters I, Mudde AN, Tan TD. Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered dose inhaler or dry powder device. J Asthma 1998 35 : 273 9.
59. Ferreira MB, Santos A, Clode MH, Carlos AGP. Turbutest in the training of asthmatic Turbuhaler users. Allergy 1999 54 : 375 9.
60. Gustafsson P, Taylor A, Zanen P, Chrystyn H. Can patients use all dry powder inhalers equally well? Int J Clin Pract 2005 59 (Suppl. 149 13 8.
61. Clay MM, Huskisson SC, Jenkins MM. Ease of handling and clinical efficacy of a new multi-dose powder inhaler for the delivery of salmeterol in adult asthmatics. Eur Respir J 1994 7 (Suppl. 18 163s.
62. Molimard M, Raherison C, Lignot S et al. Assessment of handling of inhaler device in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003 16 : 249 54.
63. Kaneko N, Narushima M, Tanaka K, Suzuki H. The efficacy of turbuhaler dry powder inhaler in Japanese asthma - measurement of peak inspiratory flow when using Turbuhaler. Jpn J Allergol 1996 45 : 649 54.
64. Hawksworth GM, James L, Chrystyn H. Characterisation of the inspiratory manoeuvre when asthmatics inhale through a Turbuhaler pre- and post- counselling in a community pharmacy. Respir Med 2000 94 : 501 4.
65. Cimas JE, Gonzalez Vazquez de Prada I, del Castillo Aravelo F. The validation of checklists for the inhalation technique for the pressurized cartridge and the Turbuhaler. Arch Bronconeumol 1999 35 : 15 9.
66. Goren A, Noviski N, Avital A et al. Assessment of the ability of young children to use a powder inhaler device (Turbuhaler). Ped Pulmonol 1994 18 : 77 80.
67. de Boeck K, Alifier M, Warnier G. Is the correct use of a dry powder inhaler (Turbuhaler) age dependent? J Allergy Clin Immunol 1999 103 : 763 7.
68. Diggory P, Fernandez C, Humphrey A, Jones V, Murphy M. Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial. BMJ 2001 322 : 1 4.
69. Burdon J, Bish R, Loder M, Walters EH. A comparison of fluticasone propionate 250 mcg bd via MDPI and budesonide 600 mcg bd via Turbuhaler in adult asthmatics. Aust N Z J Med 1997 27 : 247.
70. Backman R, Baumgarten C, Sharma RK. Fluticasone propionate via Diskus inhaler at half the microgram dose of budesonide via Turbuhaler inhaler. Clin Drug Invest 2001 21 : 735 43.
71. Arossa W, Fasolo A, Fina P. Patient perception of the Diskus inhaler: a comparison with the turbuhaler inhaler. Eur Respir J 1998 12 (Suppl. 28 41s.
72. Chapman KR, Balter MS, Boulet L-P et al. Handling of the multi-dose powder inhalers Diskus versus Turbuhaler in elderly asthmatics. Am J Respir Crit Care Med 1996 153 (4 part 2 A61.
73. Burdon J, Droszcz W, Jones R, Marques A, Trowell S. Comparison of the efficacy and ease of handling of salmeterol xinafoate delivered via a new multi-dose powder inhaler and terbutaline sulphate delivered via a breath-actuated metered dose inhaler. Eur Respir J 1995 8 (Suppl. 19 P1050.
74. Luyt D, Vermeulen J, Johnson L, Gomez E. A comparison of the ease of handling of the Diskus/Accuhaler inhaler and the turbuhaler inhaler in children aged 6-12 years with asthma. J Aerosol Med Depos Clear Eff Lung 1995 8 : P144, 105.
75. van der Palen J, Klein JJ, Schildkamp AM. Comparison of the new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998 35 : 147 52.
76. Gunawardena KA, Pleace KJ, Clay MM, Fuller RW. Salmeterol delivered from a new multi-dose powder inhaler (Diskus/Accuhaler inhaler) or Diskhaler inhaler in adult asthmatics. Am J Respir Crit Care Med 1994 149 (4 part 2 A219.
77. Boulet LP, Cowie R, Johnston P, Krakovsky D, Mark S. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. J Asthma 1995 32 : 429 36.
78. Fletcher M, Hardy AJ, Karbal B, Walker SM. Effects of asthma training on inhaler device selection and utilisation in general practice. Eur Respir J 2004 24 (Suppl. 48 257s.
79. Everard ML. Inhaler devices in infants and children: challenges and solutions. J Aerosol Med 2004 17 : 186 95.
80. Moore AC, Stone S. patient preference for the Diskus over the Handihaler in patients with COPD. Am J Respir Crit Care Med 2003 167 : A96.
81. Sharma RK, Edwards K, Hallett C, Fuller RW. Perception among paediatric patients of the Diskus inhaler, a novel multidose powder inhaler for use in the treatment of asthma. Clin Drug Invest 1996 11 : 145 53.
82. Schlaeppi M, Edwards K, Fuller RW, Sharma R. Patient perception of the Diskus inhaler: a comparison with the Turbuhaler inhaler. Br J Clin Pract 1996 50 : 14 9.
83. Giner J, Torrejón M, Ramos A et al. Patient preference in the choice of dry powder inhalers. Arch Bronconeumol 2004 40 : 106 9.
84. Wettengel R, Laurikainen K, Silvasti M, Toivanen P, Sauter K. Therapeutic equivalence and acceptability of two multidose powder inhalers in the treatment of asthma. Respiration 2000 67 : 77 82.
85. Bisgaard H. Drug delivery from inhaler devices. Lung deposition, clinical effect and cost-effectiveness vary. Br Med J 1996 13 : 895 6
86. Warren S, Taylor G, Smith J, Buck H, Parry-Billings M. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique. J Aerosol Med 2002 15 : 15 25.
87. Vidgren M, Kärkkäinen A, Karjalainen P et al. Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm 1988 42 : 211 6.
88. Vanto T, Hämäläinen KM, Vahteristo M, Wille S, Njå F, Hyldebrandt N. Comparison of two budesonide dry powder inhalers in the treatment of asthma in children. J Aerosol Med 2004 17 : 15 24.
89. Aswania O, Ritson S, Iqbal SM et al. Intra-subject variability in lung dose in healthy volunteers using five conventional portable inhalers. J Aerosol Med 2004 17 : 231 8.
90. Stoloff SW, Stempel DA, Meyer J, Stanford RH, Carranza-Rosenzweig JR. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies. J Allergy Clin Immunol 2004 113 : 245 51.
91. Stempel DA, Stanford RH, Kim J, Chernicoff HO, Legoretta A. Asthma related ED/hospitalisation risk and asthma costs of fluticasone propionate/salmeterol in a single inhaler compared to fluticasone propionate and salmeterol in separate inhalers. J Allergy Clin Immunol 2004 113 : S272.
92. GINA (Global Initiative for Asthma). Pocket Guide for Asthma Management and Prevention. http://www.ginasthma.org (accessed May 2007).
93. BTS/SIGN (British Thoracic Society/Scottish Intercollegiate Guidelines Network). British guideline on the management of asthma. Thorax 2003 58 (Suppl. 1 i1 94, http://www.brit-thoracic.org.uk.asthma-guide-download.html (accessed April 2007).
94. National Institutes of Health, National Heart, Lung and Blood Institute. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD : National Institutes of Health, 2004.
95. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996 9 : 636 42.
96. Seemungal TA, Donaldson GC, Paul EA et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 157 : 1418 22.
97. Staellaert RALM, Prins J, Greefhorst APM et al. Evaluation of a new dry powder device, the Diskus/Accuhaler versus the Diskhaler inhaler for the delivery of fluticasone propionate in adult asthmatics. J Aerosol Med Depos Clear Eff Lung 1995 8(1) : 140.
98. Le Soeuf P, Clay M. A multicentre study to evaluate ease of handling and patient preference for the Diskus/Accuhaler multi-dose dry powder inhaler. ISAM Nov 1994 abs 5.
99. Manjra AI, Mehra S, Zhang P, Mark S. Device handling comparison between Diskus (D) and Turbuhaler (TH) by paediatric patients and their parents. Eur Respir J 1998 12 (Suppl 28) : 86s.
100. Williams J, Richard KA. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Diskus inhaler compared wirg Turbuhaler inhaler in paediatric patients. Br J Clin Pract 1997 51 : 147 53.